AnaptysBio, Inc. (ANAB)
57.33
-3.22
(-5.32%)
USD |
NASDAQ |
Mar 05, 16:00
57.28
-0.05
(-0.09%)
After-Hours: 20:00
AnaptysBio Cash from Investing (Quarterly) : 73.50M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 44.87M |
| Nektar Therapeutics | -94.87M |
| Rigel Pharmaceuticals, Inc. | -25.36M |
| AbbVie, Inc. | -1.463B |
| Esperion Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 98.00M |
| Cash from Financing (Quarterly) | -43.13M |
| Free Cash Flow | 19.61M |
| Free Cash Flow Per Share (Quarterly) | 3.127 |
| Free Cash Flow to Equity (Quarterly) | 153.81M |
| Free Cash Flow to Firm (Quarterly) | 117.67M |
| Free Cash Flow Yield | 1.14% |